These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 5142348

  • 1. [Experiences with immunosuppressive treatment of multiple sclerosis].
    Wieczorek V, Lehnert W, Brodkorb W.
    Dtsch Gesundheitsw; 1971 Sep 16; 26(38):1791-4. PubMed ID: 5142348
    [No Abstract] [Full Text] [Related]

  • 2. [Aspects of immunosuppressive therapy of multiple sclerosis].
    Fischer W.
    Psychiatr Neurol Med Psychol Beih; 1975 Sep 16; 20-21():23-6. PubMed ID: 829627
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents].
    Skłodowski P.
    Neurol Neurochir Pol; 1993 Sep 16; 27(6):877-83. PubMed ID: 8164783
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Immunosuppressive treatment in multiple sclerosis].
    Vermeulen M, Zegerius L, van Crevel H.
    Ned Tijdschr Geneeskd; 1987 Jan 17; 131(3):93-6. PubMed ID: 3821989
    [No Abstract] [Full Text] [Related]

  • 8. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa, Kir'iakov VA, Sapfirova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Jan 17; 90(2):119-26. PubMed ID: 2160156
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immunosuppressive therapy of various autoimmune diseases of the nervous system].
    Neretin VIa, Odinokova VA, Kir'iakov VA, Sapfirova VA.
    Sov Med; 1990 Jan 17; (12):31-5. PubMed ID: 2097756
    [No Abstract] [Full Text] [Related]

  • 11. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
    Hommes OR.
    Ned Tijdschr Geneeskd; 1978 Oct 14; 122(41):1545-51. PubMed ID: 358004
    [No Abstract] [Full Text] [Related]

  • 12. [Current data on the etiopathogenesis of multiple sclerosis].
    Duca E.
    Neurol Psihiatr Neurochir; 1972 Oct 14; 17(5):385-94. PubMed ID: 4632587
    [No Abstract] [Full Text] [Related]

  • 13. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U, Majeron M, Mascetti A.
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb 29; 96(1):163-84. PubMed ID: 4337775
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppression for multiple sclerosis.
    N Engl J Med; 1983 Jul 28; 309(4):239-41. PubMed ID: 6866042
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The limitations of immunosuppressant therapy in Multiple Sclerosis.
    Sedal L.
    J Clin Neurosci; 2000 Nov 28; 7(6):563-4; discussion 564-5. PubMed ID: 11029245
    [No Abstract] [Full Text] [Related]

  • 18. [Multiple sclerosis. Studies on etiology and therapy].
    Bauer HJ.
    MMW Munch Med Wochenschr; 1982 Jan 29; 124(4):69-70. PubMed ID: 6801481
    [No Abstract] [Full Text] [Related]

  • 19. [Electrophoretic study of the cerebrospinal fluid proteins in multiple sclerosis. II. Influence of immunosuppressive chemotherapy].
    Castaigne P, Lhermitte F, Schuller E, Rouques C, Loridan M.
    Rev Eur Etud Clin Biol; 1971 Jan 29; 16(7):703-6. PubMed ID: 4107372
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.